RNS Number : 0303K
Gelion PLC
16 December 2022
 

 

  

The Company was notified on 16 December 2022 that Joycelyn Morton, Non-Executive Director, purchased 12,700 Ordinary Shares of 0.1p each ("Ordinary Shares") at a price of 50 pence per Ordinary Share.

 

As a result of this transaction, Joycelyn Morton's beneficial interest in the Company is 95,572 Ordinary Shares representing 0.09 per cent. of the Company's total voting rights.

 

The Company was also notified on 16 December 2022 that Michael Davie, Non-Executive Director, purchased 30,888 Ordinary Shares at a price of 51.8 pence per Ordinary Share.

 

As a result of this transaction, Michael Davie's beneficial interest in the Company is 800,681 Ordinary Shares representing 0.74 per cent. of the Company's total voting rights.

 

 

Enquiries:

 

Gelion plc

John Wood, CEO

Amit Gupta, CFO

Thomas Maschmeyer, Founder and Principal Technology Advisor

 

via Alma PR

finnCap Ltd (Nominated Adviser and Sole Broker)

+44 207 220 0500

Corporate Finance

Christopher Raggett

Seamus Fricker

Fergus Sullivan

 

ECM

Barney Hayward

 


Alma PR (Financial PR Adviser)

Justine James

Josh Royston

Hannah Campbell

Will Ellis-Hancock

+44 20 3405 0205

gelion@almapr.co.uk



 

 

The Notification of Dealing Form set out below is provided in accordance with the requirements of the EU Market Abuse Regulation.

 

1.               

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Joycelyn Morton

2.               

Reason for the Notification

a)

Position/status

Non-Executive Director

b)

Initial notification/Amendment

Initial notification

3.   

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Gelion plc

b)

LEI

2138008NC7YL3MCUDR84

4.   

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares of 0.1p each

Identification code

GB00BNBQZD59

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

 

No. of Shares

Price

12,700

£0.50

d)

Aggregated information:

·    Aggregated volume

·    Price

See above

e)

Date of the transaction

14 December 2022

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

 

1.   

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Michael Davie

2.               

Reason for the Notification

a)

Position/status

Non-Executive Director

b)

Initial notification/Amendment

Initial notification

3.   

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Gelion plc

b)

LEI

2138008NC7YL3MCUDR84

4.   

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares of 0.1p each

Identification code

GB00BNBQZD59

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

 

No. of Shares

Price

30,888

£0.518

d)

Aggregated information:

·    Aggregated volume

·    Price

See above

e)

Date of the transaction

16 December 2022

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBBBDDRXBDGDL